Christine Belgio, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 330 N 12th St Ste A, Sunbury, PA 17801 Phone: 570-286-0303 |
Emily Ann Haas, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 409 N 4th St, Sunbury, PA 17801 Phone: 570-286-1482 Fax: 570-286-5243 |
Ms. Kristen Ann Cheslick, CRNP Nurse Practitioner - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 350 N 11th Street, Sunbury, PA 17801 Phone: 570-286-3430 Fax: 570-288-8065 |
Helga Faust, CRNP, FNP - C Nurse Practitioner - Primary Care Medicare: Accepting Medicare Assignments Practice Location: 385 State St, Sunbury, PA 17801 Phone: 570-286-6773 |
Eugene T Lucas, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 350 Nth 11th Street, Sunbury, PA 17801 Phone: 570-286-3430 |
Mrs. Noreen Elaine Chikotas, CRNP MSN DED Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 335 Market St, Sunbury, PA 17801 Phone: 570-988-1270 Fax: 570-286-4050 |
Kayla Jo Woods, Nurse Practitioner - Gerontology Medicare: Not Enrolled in Medicare Practice Location: 901 Court St, Sunbury, PA 17801 Phone: 570-286-7121 |
News Archive
On Thursday, President Obama met with a newly elected governors - many from the GOP - to defend his health overhaul plan. It wasn't a completely friendly meeting. Meanwhile, on Capitol Hill, a Republican lawmaker stated his intent to work tirelessly for repeal.
MIS416, a novel microparticle-based immune response modifier, demonstrated the ability to significantly reduce the number and size of metastatic tumors in preclinical mouse models of lung and breast cancers, Innate Therapeutics (formerly Virionyx Corporation) announced.
In a screening for a functional impact to the neuronal differentiation process, Danish researchers identified a specific circular RNA, circZNF827, which surprisingly "taps the brake" on neurogenesis.
OPKO Health, has acquired CURNA, a privately held company based in Jupiter, Florida, engaged in the discovery of new drugs for the treatment of a wide variety of illnesses, such as cancer, heart disease, metabolic disorders and genetic anomalies.
Myconostica Ltd, the UK-based medical diagnostic company developing and commercialising rapid and highly specific tests for life-threatening fungal infections, today announces the CE marking of its lead product MycAssay™ Aspergillus for detection of Aspergillus DNA in serum.
› Verified 8 days ago